US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 22.370
  • -0.340-1.50%
Close Dec 27 16:00 ET
  • 22.370
  • 0.0000.00%
Post 16:03 ET
1.09BMarket Cap-12.41P/E (TTM)

Enliven Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enliven Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Enliven Therapeutics Earnings Reports

  • Enliven Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 16:20 ET

  • Enliven Therapeutics | 8-K: Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update

    Nov 13 16:16 ET

  • Enliven Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:19 ET

  • Enliven Therapeutics | 8-K: Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

    Aug 13 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data